Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Rewalk Roboti Ord Sh (RWLK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,897
  • Shares Outstanding, K 35,520
  • Annual Sales, $ 7,750 K
  • Annual Income, $ -24,720 K
  • 36-Month Beta 0.65
  • Price/Sales 4.17
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.78
  • Most Recent Earnings -0.22 on 11/02/17
  • Next Earnings Date 11/01/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.15
  • Number of Estimates 1
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +31.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.88 +0.59%
on 09/20/18
1.07 -17.25%
on 08/22/18
-0.13 (-13.20%)
since 08/20/18
3-Month
0.70 +26.49%
on 07/19/18
1.35 -34.41%
on 07/20/18
-0.14 (-13.62%)
since 06/20/18
52-Week
0.70 +26.49%
on 07/19/18
1.65 -46.34%
on 09/27/17
-0.81 (-47.92%)
since 09/20/17

Most Recent Stories

More News
ReWalk Robotics (RWLK) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether ReWalk Robotics ("ReWalk" or the "Company") (NASDAQ: RWLK) and certain of...

RWLK : 0.89 (-1.40%)
ReWalk Robotics to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6th

ReWalk Robotics Ltd. ("ReWalk" or the "Company") (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will present at the H.C. Wainwright 20th...

RWLK : 0.89 (-1.40%)
ReWalk Robotics Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 14, 2018 / ReWalk Robotics Ltd. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 14, 2018 at 8:30 AM Eastern Time.

RWLK : 0.89 (-1.40%)
Today's Research Reports on Stocks to Watch: ReWalk Robotics and iRobot

NEW YORK, NY / ACCESSWIRE / July 23, 2018 / Shares of ReWalk soared over 70% on Friday after the company announced that the U.S. Department of Veterans Affairs has issued a revision to its national policy...

RWLK : 0.89 (-1.40%)
U.S. Department of Veterans Affairs Expands Access to ReWalk Exoskeletons for Paralyzed Veterans with Revised National Policy

ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company") announced that the U.S. Department of Veterans Affairs has issued a revision to its national policy on exoskeleton medical device training...

RWLK : 0.89 (-1.40%)
ReWalk Completes Amendment with Wyss Institute at Harvard University to Extend Agreement to June 2022

ReWalk Robotics, Ltd. (Nasdaq:RWLK) ("ReWalk" or the "Company") announced today that the Company has completed an amendment to the working agreement with the Wyss Institute at Harvard University (Wyss)....

RWLK : 0.89 (-1.40%)
ReWalk Announces Progress in Clinical Study of ReStore Powered Exo-Suit

ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced today that the Institutional...

RWLK : 0.89 (-1.40%)
Global Rehabilitation Robots Market 2018-2022 - Key Vendors are Cyberdyne, Ekso Bionics, Parker Hannifin, ReWalk Robotics & Rex Bionics - ResearchAndMarkets.com

The "Global Rehabilitation Robots Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

EKSO : 2.09 (-0.95%)
RWLK : 0.89 (-1.40%)
ReWalk Personal 6.0 Exoskeleton Added to the Official German List of Medical Aids

ReWalk Robotics, Ltd. (Nasdaq:RWLK) ("ReWalk" or "the Company") announced today that the Company's ReWalk Personal 6.0 Exoskeleton System has been included in the official list of medical aids (Hilfsmittelverzeichnis)...

RWLK : 0.89 (-1.40%)
ReWalk Robotics Receives First Tranche of $5 Million as Part of $20 Million Strategic Investment from Timwell Corporation Limited

-- ReWalk to commence strategic partnership with Timwell to commercialize ReWalk products in China --

RWLK : 0.89 (-1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade RWLK with:

Business Summary

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. The Company's exoskeletons allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. It offers ReWalk...

See More

Key Turning Points

2nd Resistance Point 0.93
1st Resistance Point 0.91
Last Price 0.89
1st Support Level 0.89
2nd Support Level 0.88

See More

52-Week High 1.65
Fibonacci 61.8% 1.29
Fibonacci 50% 1.17
Fibonacci 38.2% 1.06
Last Price 0.89
52-Week Low 0.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar